This is a ready-to-use contingency plan for an international cold chain lane carrying an advanced therapy product. The shipping lane risk assessment scores customs exposure as a risk factor; this plan is the documented response for when that risk actually happens mid-transit, not a restatement of the score. Complete it before a lane’s first international shipment, not after its first real hold. Replace every <<FILL: ...>> placeholder and route it through your normal document control, review, and approval. A worked filled specimen follows.
Document control header
| Field | Entry |
|---|---|
| Document title | International Shipment Customs and Import Contingency Plan for <<FILL: lane / product>> |
| Document number | <<FILL: e.g. PLN-LOG-019>> |
| Linked shipping lane risk assessment | <<FILL: ref>> |
| Document owner | <<FILL: e.g. Head of Cold Chain Logistics>> |
1. Scope
| Dimension | Decision |
|---|---|
| Lane(s) in scope | <<FILL: origin, destination, border crossings>> |
| Product(s) in scope | <<FILL>> |
| Out of scope | <<FILL: e.g. fully domestic lanes with no customs exposure, covered by the standard shipping qualification protocol alone>> |
2. Regulatory and customs backdrop
| Reference | What it covers for this lane |
|---|---|
| WHO Technical Report Series 961, Annex 9, Model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products (2011) | Model international framework for temperature-sensitive distribution |
| WHO Technical Report Series 1025, Annex 7, Good storage and distribution practices for medical products (2020) | Broader distribution quality system this lane’s transport sits inside |
| EU Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use (2013/C 343/01), where the lane touches the EU | Distribution quality expectations for EU wholesale distribution, including the chapter on returns and suspected falsified product |
| US Customs and Border Protection entry filing via the Automated Commercial Environment, and FDA admissibility review, where the lane enters the US | The import clearance process this plan’s contingency actions are built around |
<<FILL: any additional destination-country customs or import regime specific to this lane>> | <<FILL>> |
3. Named contacts
| Role | Name | Contact method | Backup |
|---|---|---|---|
| Customs broker / import agent | <<FILL>> | <<FILL>> | <<FILL>> |
| Logistics coordinator (primary responder) | <<FILL>> | <<FILL>> | <<FILL>> |
| Quality on-call | <<FILL>> | <<FILL>> | <<FILL>> |
| Local courier or coolant resupply contact near the port of entry | <<FILL>> | <<FILL>> | <<FILL>> |
4. Pre-staged documentation
| Document | Staged where | Confirmed current as of |
|---|---|---|
| Product identity and import declaration records | <<FILL>> | <<FILL>> |
| Import license or permit, where required | <<FILL>> | <<FILL>> |
| Prior entry history for this product and lane | <<FILL>> | <<FILL>> |
| ATA Carnet, for reusable shipping equipment making a recurring international crossing, where applicable | <<FILL: carnet number and expiry, or "Not applicable">> | <<FILL>> |
5. Rescue options if a hold runs long
| Option | Availability on this lane | Trigger to execute |
|---|---|---|
| Re-icing or coolant top-up near the port of entry | <<FILL: location, contact, lead time>> | <<FILL: e.g. hold estimated to exceed 50 percent of remaining qualified duration>> |
| Expedited alternate clearance path (e.g. broker-initiated urgent review request) | <<FILL>> | <<FILL>> |
| Written off as probable loss | Always available as the final option | Remaining qualified duration reaches zero with no rescue executed |
6. Response table
| Hold scenario | Immediate action | Who owns it |
|---|---|---|
| Routine clearance, no delay | Confirm clearance against expected timeline | Courier or broker |
| Flagged for additional information request | Provide pre-staged documentation immediately | Broker, with regulatory affairs support |
| Flagged for physical examination | Notify Quality and logistics; begin tracking remaining qualified duration against the hold’s estimated length | Broker notifies logistics; logistics notifies Quality |
| Hold threatens to exceed remaining qualified duration | Execute the rescue option that applies, per section 5 | Quality and logistics jointly |
| Hold resolved but duration exceeded the qualified window | Treat as a probable excursion regardless of logger reading; route to the excursion investigation process | Quality |
7. Roles
| Role | Responsibility |
|---|---|
| Logistics coordinator | Monitors shipment status, contacts the broker, executes tier 1 response per the paired In-Transit Shipment Monitoring and Alert Escalation SOP |
| Customs broker / import agent | Provides pre-staged documentation on request, advises on clearance status and realistic timelines |
| Quality | Tracks remaining qualified duration against the hold, decides when a hold becomes a probable excursion, leads disposition planning |
| Regulatory affairs | Confirms import license, permit, and prior-entry documentation stays current for the lane |
8. Acceptance
| Field | Entry |
|---|---|
| Every named contact confirmed reachable and current | <<FILL: Yes/No, date confirmed>> |
| Every pre-staged document confirmed current | <<FILL: Yes/No, date confirmed>> |
| At least one rescue option identified for this lane, or documented as unavailable with a risk acceptance | <<FILL>> |
| Approved by (Quality, name, date) | <<FILL>> |
9. References
See the paired article, cold chain for advanced therapies: qualifying cryoshippers and dry-vapor shippers, for the reasoning behind treating customs exposure as a contingency question, not only a risk score. WHO Technical Report Series 961, Annex 9 (2011), and Technical Report Series 1025, Annex 7 (2020). EU Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use (2013/C 343/01). US Customs and Border Protection, Automated Commercial Environment filing requirements for FDA-regulated entries.
Confirm the current version of each reference before issue.
10. Revision history
| Version | Date | Author | Summary of change |
|---|---|---|---|
<<FILL: 1.0>> | <<FILL>> | <<FILL>> | Initial issue. |
11. Approvals
| Role | Name | Signature | Date |
|---|---|---|---|
| Author (Logistics) | <<FILL>> | ||
| Reviewer (Regulatory Affairs) | <<FILL>> | ||
| Approver (Quality) | <<FILL>> |
Filled specimen
Extract for a CAR-T product lane from a European manufacturing site into the United States.
| Field | Entry |
|---|---|
| Lane | <<FILL: site A>> to a US clinical site, with routine CBP entry filing through the Automated Commercial Environment |
| Named broker | M. Castellano, confirmed reachable 24/7 for active shipments, backup contact confirmed |
| Pre-staged documentation | Product identity and import declaration records refreshed quarterly; no import license required for this product class; prior entry history clean across 11 prior shipments |
| Rescue option | A regional courier partner near the port of entry can deliver dry ice or arrange a dry vapor shipper recharge within 3 hours of request |
| Event | Shipment flagged for a routine physical examination at entry, estimated 5-hour hold against roughly 30 hours of remaining qualified transit duration |
| Response | Broker notified logistics within 20 minutes per the monitoring SOP; pre-staged documentation provided proactively; Quality tracked remaining duration throughout; hold resolved in 4 hours with the rescue option never triggered |
| Disposition | No excursion; logger data and hold correspondence retained together as the shipment record |
Common inspection findings this plan prevents
- A lane scored as having customs exposure risk with no actual contingency plan behind the score.
- A broker contact that exists informally in one coordinator’s phone, with no backup and no documented confirmation of reachability.
- Import documentation that would have shortened a hold, sitting unassembled until after the hold already started.
- No defined decision point for when a long hold gets treated as a probable excursion, leaving the shipment in limbo past its qualified window with no disposition path started.
- Reusable shipping equipment paying full import duty on every international crossing with no evaluation of whether an ATA Carnet applies.
How to adapt this plan
- Name real individuals and confirm their reachability before this lane’s first international shipment, not after.
- Assemble and date-stamp the pre-staged documentation list in section 4 before it is needed under pressure.
- Confirm whether a rescue option genuinely exists near this lane’s actual port of entry; do not assume one without checking.
- Set the decision point in section 5 and 6 against this lane’s real qualified duration, not a generic assumption.